Ruka hadi maudhui makuu
Taratibu

What is precision oncology?

Timu ya uhariri ya Medcasts

Precision oncology means using your tumor's molecular profile (genetic mutations, gene expression, protein markers) to select treatment, rather than treating based on cancer organ alone.

A breast cancer with HER2 amplification gets HER2-targeted therapy (trastuzumab, pertuzumab). A lung cancer with EGFR mutation gets an EGFR inhibitor (osimertinib). A colon cancer with BRAF mutation gets BRAF-targeted therapy.

Practical implication: insist that your tumor's molecular profile is documented before treatment is finalized. The right tests depend on the cancer; common panels include comprehensive genomic profiling (FoundationOne, Tempus, Caris) or focused testing for specific markers.

Not every cancer has a targetable mutation. But missing one when it's there is the most common avoidable mistake in modern oncology.

Jibu hili ni taarifa ya jumla, si ushauri wa kitabibu. Daktari wako anapaswa kuthibitisha kinachohusu hali yako.

Maswali yote

Unataka jibu kwa hali yako?

Tuma ripoti zako mara moja. Daktari anazipitia na unapata makadirio ya maandishi kutoka hadi hospitali 3, bure.

Jinsi ukurasa huu ulivyoandaliwa

Mbinu na viwango vya uhariri

Majibu yanaandikwa na timu ya uhariri ya Medcasts na kusasishwa bei, miongozo au sheria za viza zinapobadilika.

  1. Taarifa za hospitali. Ithibati, leseni na vifaa vinakaguliwa kwenye rejista za umma (JCI, NABH, orodha za leseni za wizara za afya) na nyaraka za hospitali, na kukaguliwa upya mara kwa mara.
  2. Sifa za madaktari. Elimu na utaalamu vinatoka kwenye wasifu wa daktari hospitalini na rejista za mabaraza ya madaktari ya kitaifa.
  3. Bei. Viwango vya bei vinatoka kwenye makadirio na vifurushi vya maandishi vya hospitali, si bei za matangazo.
  4. Maandishi ya kitabibu. Yanaandikwa na timu yetu ya uhariri na kukaguliwa dhidi ya miongozo ya sasa kabla ya kuchapishwa.
  5. Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.